Meprobamate Addiction
- 30 October 1958
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 259 (18) , 865-868
- https://doi.org/10.1056/nejm195810302591804
Abstract
A LITTLE over three and a half years ago, a new medication, meprobamate, was widely promoted for use in a variety of maladies. There is no doubt of its efficacy as a muscle relaxant and mild sedative. One of the most important factors that caused it to be widely accepted was its apparent freedom from toxic side effects and addiction.1 It is fortunate that meprobamate is relatively innocuous in comparison to other types of so-called "relaxing" or "tranquilizing" drugs, and as such it has been accepted by a large proportion of the lay population as a harmless panacea for a . . .Keywords
This publication has 21 references indexed in Scilit:
- Complications from the Use of Tranquilizing DrugsNew England Journal of Medicine, 1957
- TOXIC REACTION TO 2-METHYL-2-N-PROPYL-1,3, PROPANEDIOL DICARBAMATE (MILTOWN AND EQUANIL)Annals of Internal Medicine, 1957
- TREATMENT OF ANXIETY STATES WITH MEPROBAMATEAnnals of the New York Academy of Sciences, 1957
- ALLERGENICITY OF TRANQUILIZING DRUGSJAMA, 1957
- Drug Eruptions Due to MeprobamateNew England Journal of Medicine, 1957
- Nonthrombocytopenic Purpura Due to Miltown (2-Methyl-2-N-Propyl-1,3 Propanediol Dicarbamate)New England Journal of Medicine, 1956
- REACTIONS TO MEPROBAMATEJAMA, 1956
- DRUG HABITUATIONJAMA, 1956
- CLINICAL STUDY OF A NEW TRANQUILIZING DRUGJAMA, 1955
- STUDY OF EFFECT OF MILTOWN (2-METHYL-2-N-PROPYL-1,3-PROPANEDIOL DICARBAMATE) ON PSYCHIATRIC STATESJAMA, 1955